According to the Food and Drug Administration (FDA), Bristol-Myers Squibb announced an update to the U.S. labeling for Tequin (gatifloxacin) tablets and injection on February 15, 2006.

Molecular Diagnosis and Treatment Center for Infectious Diseases, Dermatology Hospital, Southern Medical University, No.2 Lujing Road, Yuexiu District, Guangzhou 510091, Guangdong, China Institute for ...